Phase 4Completed

Acceptance and Preference of Lidocaine Gel Compared to Injection Anesthesia After Non Surgical Periodontal Treatment

Multicenter, Randomized, Split-mouth Study to Evaluate the Acceptance and Preference of Lidocaine Gel Compared to Injection Anesthesia After Non Surgical Periodontal Treatment

Sponsor
Chemische Fabrik Kreussler & CO GmbH (Industry)
Enrollment
94 enrolled
Conditions
Periodontitis
Interventions
Lidocaine Hydrochloride 1% Gel; Articaine hydrochloride/epinephrine (adrenaline) hydrochloride
Ages
adults, older adults
Registry
NCT03354312

Full record on ClinicalTrials.gov

From the registry

This project is a national, open label, multicenter, randomized split-mouth study in patients from 18 to 70 years of age to compare the efficacy and acceptability of lidocaine gel compared to injection anesthesia with articaine (infiltration anesthesia for the upper jaw and infiltration or nerve block anesthesia for the lower jaw). It is planned that about 90 patients with a proven moderate periodontitis will be enrolled in 5 German study centers. Dynexan Mundgel® (lidocaine hydrochloride) is a topical anesthetic gel containing lidocaine that is commercially available as an anesthetic for temporary, symptomatic treatment of pain at the oral mucosa, gingiva and lips. The gold standard for scaling and root planing (SRP) is still the use of injection anesthesia. This raises the question what kind of anesthesia patients would prefer if they had a free choice. For this study Ultracaine® D-S 1:200,000 (articaine hydrochloride/epinephrine hydrochloride) was selected as the injectable comparator drug because it is the most frequently used anesthetic drug for infiltration and nerve-block…

Primary outcomes

  • Acceptance and preference of topical lidocaine mouth gel anesthesia

History

  1. Last registry update

  2. Primary completion

  3. Started

  4. Registered